Skip to main content

Table 3 Comparative gene expression levels from microarray and RT-PCR analysis

From: Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line

Gene Description Microarray 48 h Fold Change RT-PCR 48 h Fold Change
IL-11 interleukin 11 -4.59 -2.13
CDK11 cyclin-dependent kinase (CDC2-like) 11 128.00 4.03
FRK fyn-related kinase 25.99 11.00
p15 cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 9.19 5.41
CHD2 chromodomain helicase DNA binding protein 2 14.93 15.74
CNOT CCR4-NOT transcription complex, subunit 3 -4.29 -5.01
p57 cyclin-dependent kinase inhibitor 1C (p57, Kip2) 6.06 35.84
ELF3 E74-like factor 3 (ets domain transcription factor) 6.96 24.53
ACVR activin A receptor, type IIB 11.31 2.95
TNFSF tumor necrosis factor (ligand) superfamily, member 15 11.31 30.00
EGFR epidermal growth factor receptor 2.00 6.00
p27 cyclin-dependent kinase inhibitor 1B (p27, Kip1) 3.03 10.90
KRAS2 v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog 19.7 3.56
FGF fibroblast growth factor -6.06 -5.26